Tag: Biomarker data
Biohaven gives important update on phase 2/3 trial and Alzheimer’s disease...
Biohaven Pharmaceutical Holding Company Ltd has announced completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical...
